Advertisement

Autoantigen (64000-Mr) Expression in Coxsackievirus B4-Induced Experimental Diabetes

Conference paper
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 156)

Abstract

Extensive epidemiologic observations (GAMBLE et al. 1969; GAMBLE 1980; BARRET-CONNOR 1985), many case reports, and animal studies (CRAIGHEAD 1975; NOTKINS 1977) have associated group B coxsackieviruses in the etiology of type 1, insulin-dependent diabetes mellitus (IDDM). IDDM in human patients is rare until 9 months of age and has peaks of onset at 5–8 years and again at 10–14 years of age (GAMBLE 1977). These observations are consistent with epidemiological patterns of many infections, which are prevented by maternal immunity and have peaks at the time of entry into school and at early puberty.

Keywords

Beta Cell IDDM Patient Susceptible Mouse Insulin mRNA Islet Cell Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andersen OO, Christy M, Arnung K, Buschard K, Christau B, Kromann H, Nerup J, Platz P, Ryder LP, Svejgaard A, Thomsen M (1977) Viruses and diabetes. In: Bajaj JS(ed) Diabetes. Excerpta Medica, Amsterdam, pp 294–298Google Scholar
  2. Baekkeskov S, Lernmark A (1982) Rodent islet cell antigens recognized by antibodies in sera from diabetic patients. Acta Biol Med Ger 4: 111–115Google Scholar
  3. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A (1982) Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 298: 167–169PubMedCrossRefGoogle Scholar
  4. Baekkeskov S, Dyrberg T, Lernmark A (1984) Autoantibodies to a 64-kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science 224: 1348–1350PubMedCrossRefGoogle Scholar
  5. Baekkeskov S, Landin M, Kristensen JK, Srikanta S, Bruining GJ, Poulsen TM, Beaufort C, Soeldner JS, Eisenbarth G, Lindgren F, Sundquist G, Lernmark A (1987) Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 79: 926–934PubMedCrossRefGoogle Scholar
  6. Barret-Connor E (1985) Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence. Rev Infect Dis 7: 207–215CrossRefGoogle Scholar
  7. Bottazzo GF, Dean BM, McNally JM, Mackay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313: 353–360PubMedCrossRefGoogle Scholar
  8. Bowles NE, Olsen EG J, Richardson PJ, Archard LC (1986) Detection of coxsackie B virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1: 1120–1123PubMedCrossRefGoogle Scholar
  9. Bruserud O, Jervell J, Thorsby E (1985) HLA-DR3 and DR4 control T-lyiphocyte responses to mumps and coxsackie B4 virus: studies on patients with Type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia 28: 420–426PubMedCrossRefGoogle Scholar
  10. Chatterjee NK, Nejman C (1988) Insulin NA content in pancreatic beta cells of coxsackievirus B4-induced diabetic mice. Mol Cell Endocrinol 55: 193–202PubMedCrossRefGoogle Scholar
  11. Chatteijee NK, Tuchowski C (1981) Comparison of capsid polypeptides of group B coxsackieviruses and polypeptide synthesis in infected cells. Arch Virol 70: 255–269CrossRefGoogle Scholar
  12. Chatterjee NK, Haley TM, Nejman C (1985) Functional alterations in pancreatic B cells as a factor in virus-induced hyperglycemia in mice. J Biol Chem 260: 12786–12791PubMedGoogle Scholar
  13. Chatterjee NK, Nejman C, Gerling I (1988) Purification and characterization of a strain of coxsackievirus B4 of human origin that induces diabetes in mice. J Med Virol 26: 57–69PubMedCrossRefGoogle Scholar
  14. Chatterjee NK, Gerling I, Nejman C (1989) Pancreatic D-cell disorder in Coxsackie-virus B4-induced diabetic mice. Mol Cell Endocrinol 67: 39–45PubMedCrossRefGoogle Scholar
  15. Craighead JE (1975) The role of viruses in the pathogenesis of pancreatic diseases and diabetes mellitus. Prog Med Virol 19: 161–214PubMedGoogle Scholar
  16. Gamble DR (1977) Viruses and diabetes: an overview with special reference to epidemiological studies. In: Bajaj JS (ed) Diabetes. Excerpta Medica, Amsterdam, pp 283–293Google Scholar
  17. Gamble DR (1980) The epidemiology of insulin dependent diabetes, with particular reference to the relationship of virus infection to its etiology. Epidemiol Rev 2: 49–70PubMedGoogle Scholar
  18. Gamble DR, Kinsley ML, Fitzgerald MG, Bolton R, Taylor KW (1969) Viral antibodies in diabetes mellitus. Br Med J 3: 627–630PubMedCrossRefGoogle Scholar
  19. Gerling I, Baekkeskov S, Lernmark A (1986) Islet cell and 64K autoantibodies are associated with plasma IgG in newly diagnosed insulin-dependent diabetic children. J Immunol 137: 3782–3785PubMedGoogle Scholar
  20. Gerling I, Nejman C, Chatterjee NK (1988) Effect of coxsackievirus B4 infection in mice on expression of 64,000 Mr autoantigen and glucose sensitivity of islets before development of hyperglycemia. Diabetes 37: 1419–1425PubMedCrossRefGoogle Scholar
  21. Gerling I, Chatterjee NK, Nejman C (1990) Development of 64,000-Mr autoantibodies in coxsackievirus B4-induced hyperglycemic mice, (submitted)Google Scholar
  22. Hartig PC, Webb SR (1983) Heterogeneity of a human isolate of coxsackie B4: biological differences. J Infect 6: 43–48PubMedCrossRefGoogle Scholar
  23. Hartig PC, Madge GE, Webb SR (1983) Diversity within a human isolate of coxsackie B4: relationship to viral-induced diabetes. J Med Virol 11: 23–30PubMedCrossRefGoogle Scholar
  24. Hazva DK, Singh R, Wahal PK, Gupta MK, Jain NK, Elhence BR (1980) Coxsackie antibodies in young Asian diabetics. Lancet 1: 877Google Scholar
  25. Hedeskov CJ (1980) Mechanism of glucose-induced insulin secretion. Physiol Rev 60: 442–507PubMedGoogle Scholar
  26. Jordan GW, Bolton V, Schmidt NJ (1985) Diabetogenic potential of coxsackie B viruses in nature. Arch Virol 86: 213–221PubMedCrossRefGoogle Scholar
  27. Kanatsuna T, Baekkeskov S, Lernmark A, Ludvigsson J (1983) Immunoglobulin from insulin-dependent diabetic children inhibits glucose-induced insulin release. Diabetes 32: 520–524PubMedCrossRefGoogle Scholar
  28. Kibrick S, Benirschke K (1958) Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with coxsackievirus group B. Pediatrics 22: 857–875PubMedGoogle Scholar
  29. McCartney RA, Banatvala JE, Bell EJ (1986) The routine use of µ-antibody capture ELISA for the serological diagnosis of coxsackie B virus infection. J Med Virol 19: 205–212PubMedCrossRefGoogle Scholar
  30. Montgomery LB, Loria RM (1988) The use of coxsackievirus B4 to probe immunodeficiencies associated with hereditary and overt diabetes mellitus. Diabetes 7: 209AGoogle Scholar
  31. Notkins AL (1977) Virus-induced diabetes mellitus. Arch Virol 54: 1–17PubMedCrossRefGoogle Scholar
  32. Oldstone MBA, Southern P, Rodriguez M, Lampert PW (1984) Virus persists in beta cells and islets of Langerhans and is associated with chemical manifestation of diabetes. Science 224: 1440–1444PubMedCrossRefGoogle Scholar
  33. Palmer JP, Cooney MK, Ward RH, Hansen JA, Brodsky JB, Ray CG, Crossley JR, Asplin CM, Williams RH (1982) Reduced coxsackie antibody titers in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of coxsackie B3 and B4 infection. Diabetologia 22: 426–429PubMedCrossRefGoogle Scholar
  34. Prabhakar BS, Haspel MV, McClintock PR, Notkins AL (1982) High frequency of antigenic variants among naturally occurring human coxsackie B4 virus isolates identified by monoclonal antibodies. Nature 300: 374–376PubMedCrossRefGoogle Scholar
  35. Schernthaner G, Scherbaum W, Borkenstein M, Banatvala JE, Bryant J, Schober E, Mayr WR (1985) Coxsackie-B-Virus specific IgM responses, complement fixing islet-cell antibodies HLA-DR antigens and C-peptide secretion in insulin-dependent diabetes mellitus. Lancet 2: 630–632PubMedCrossRefGoogle Scholar
  36. Schmidt WAK, Brade L, Munterfering H, Klein M (1978) Course of coxsackie B antibodies during juvenile diabetes. Med Microbiol Immunol (Berl) 164: 291–298CrossRefGoogle Scholar
  37. Svejgaard A, Platz P, Ryder LP (1983) HLA and disease 1982-a survey. Immunol Rev 70: 193–218PubMedCrossRefGoogle Scholar
  38. Toniolo A, Onodera T, Yoon JW, Notkins AL (1980) Induction of diabetes by cumulative environmental insults from viruses and chemicals. Nature 288: 383–385PubMedCrossRefGoogle Scholar
  39. Toniolo A, Federico G, Basolo F, Onodera T (1988) Diabetes mellitus. In: Bendinelli M, Friedman H (ed) Coxsackieviruses-a general update. Plenum, New York, pp 351–382Google Scholar
  40. Webb SR, Madge GE (1980) The role of host genetics in the pathogenesis of coxsackievirus infection in the pancreas of mice. J Infect Dis 141: 47–54PubMedCrossRefGoogle Scholar
  41. Webb SR, Loria RM, Kibrick S (1976) Susceptibility of mice to group B coxsackievirus is influenced by the diabetic gene. J Exp Med 143: 1239–1248PubMedCrossRefGoogle Scholar
  42. Wegner U, Kewitsch A, Madauss M, Dohner L, Zuhlke H (1985) Hyperglycemia in Balb/c mice after pretreatment with an subdiabetogenic dose of streptozotocin and subsequent infection with a coxsackie B4 strain. Biomed Biochim Acta 44: 21–27PubMedGoogle Scholar
  43. Yale JF, Grose M, Seemayer TA, Marliss EB (1988) Diabetes prevention in BB rats by frequent blood withdrawal started at a young age. Diabetes 37: 327–333PubMedCrossRefGoogle Scholar
  44. Yoon JW, Onodera T, Notkins AL (1978) Virus-induced diabetes mellitus: beta cell damage and insulin dependent hyperglycemia in mice infectiod with coxsackievirus B4. J Exp Med 148: 1068–1080PubMedCrossRefGoogle Scholar
  45. Yoon JW, Austin M, Onodera T, Notkins AL (1979) Virus-induced diabetes mellitus. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300: 1173–1179PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1990

Authors and Affiliations

  1. 1.New York State Department of HealthWadsworth Center for Laboratories and ResearchAlbanyUSA

Personalised recommendations